XML 36 R26.htm IDEA: XBRL DOCUMENT v3.24.3
Net Loss Per Share Attributable to Common Stockholders
 9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
Net Loss Per Share Attributable to Common Stockholders Net Loss Per Share Attributable to Common Stockholders
The following table presents the calculation of basic and diluted loss per share attributable to common stockholders (in thousands, except share and per share data):

For the Three Months Ended September 30,For the Nine Months Ended September 30,
2024202320242023
Net Loss $(4,435)$(2,703)$(21,747)$(8,897)
Less: Preferred stock return and dividend(185)— (496)— 
Less: Deemed dividend(54)— (514)— 
Net Loss Attributable to Common Stockholders, basic and diluted$(4,674)$(2,703)$(22,757)$(8,897)
Net Loss Per Share - Basic and Diluted$(0.13)$(0.66)$(1.23)$(2.26)
Weighted Average Shares Outstanding, Basic and Diluted34,986,105 4,116,700 18,439,744 3,931,075 

The basic earnings per share calculation for the three months ended September 30, 2024 and 2023 included 209,688 and 608,528 penny warrant shares, respectively, since the exercise price was $0.01 per share. The basic earnings per share calculation for the nine months ended September 30, 2024 and 2023 included 608,528 and 608,528 of penny warrants shares, respectively. Additionally, the basic earnings per share calculation for the three months ended September 30, 2023 and for the nine months ended September 30, 2024 and 2023 included 298,395 shares of common stock that were issuable to Xeriant Inc. ("Xeriant") related to the joint venture arrangement that expired by its term on May 31, 2023. The shares were issued to Xeriant for no additional consideration immediately prior to the XTI Merger.
The following potentially dilutive shares were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive (on an as-converted basis):

For the Three Months Ended September 30,For the Nine Months Ended September 30,
2024202320242023
Options12,818,530 1,161,688 5,791,342 1,095,195 
Warrants278,963 163,603 457,094 142,276 
Convertible preferred stock2 — 2 — 
Convertible notes— 679,828 345,695 650,027 
Total13,097,495 2,005,119 6,594,133 1,887,498